Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 98 results found. Search for [ essential%20drugs ]

Results 40 to 60 of 98
www.businesstoday.in
March 30, 2015
Union Minister of State for Chemicals & Fertilisers Hansraj Gangaram Ahir has announced a Rs 900-crore revival package for IDPL, which has almost come to a standstill in terms of operations.


www.businesstoday.in
New Delhi, March 19, 2015
The government has exempted drugs and pharmaceuticals from the the levy of Education Cess and Secondary and Higher Education Cess, resulting into reduction of excise duty from 6.18 per cent to 6 per cent.


www.businesstoday.in
New Delhi, March 3, 2015
Out of 509 drugs, above 40 per cent price reduction has happened in the case of 127 essential medicines, while prices of 34 drugs has come down in the range of 35-40 per cent,


www.businesstoday.in
New Delhi, December 26, 2014
The government sought to put controls on drugmakers when it came to pricing of essential drugs, including those for common cough and cold as also for cancer and other diseases.


www.businesstoday.in
December 24, 2014
Sun Pharmaceutical's move to acquire Ranbaxy is arguably the high point of 2014 for the pharmaceutical sector.


www.businesstoday.in
Mumbai, December 12, 2014
Besides commonly-used antibiotics and pain-killers, the new drugs to come under price control include medicines used for treating cancer and skin disorders.


www.businesstoday.in
December 6, 2014
\"We are clearly disappointed by the outcome and do feel it raises questions on the future viability of this business,\" Manni Kantipudi, CEO of GVK Biosciences told.


www.businesstoday.in
New Delhi, December 2, 2014
The government in considering the free essential drugs scheme in a bid to bring down out-of-pocket expenditure of an individual on health care.


www.businesstoday.in
November 17, 2014
From a business model innovation perspective, I believe the companies need to leverage both their wealth of experience and market realities.


www.businesstoday.in
Mumbai, October 30, 2014
Under the National Health Assurance Mission, Prime Minister Narendra Modi's government would provide all citizens with free drugs and diagnostic treatment, as well as insurance cover to treat serious ailments.


www.businesstoday.in
Mumbai, October 13, 2014
The Swiss drugmaker, which did not confirm the quantum of the total penalty by the the National Pharmaceutical Pricing Authority (NPPA), said the notice is \"erroneous and entirely misconceived\".


www.businesstoday.in
September 24, 2014
\"This is for the first time, I think, that a pharma policy has been rolled back... It is a very positive move,\" Biocon Chairperson and MD Kiran Mazumdar-Shaw said.


www.businesstoday.in
Mumbai, September 23, 2014
The government has withdrawn guidelines issued on May 29 that gave the drug pricing regulator power to fix prices of drugs deemed non-essential.


www.businesstoday.in
New Delhi, September 20, 2014
Major drug companies, including Cipla, Ranbaxy, Lupin and Cadila, are likely to be impacted by the decision.


www.businesstoday.in
New Delhi/Mumbai, September 19, 2014
Drugmakers, including Cipla, Ranbaxy Laboratories, and Cadila Healthcare are among the companies that will be affected by the latest decision.


www.businesstoday.in
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.


www.businesstoday.in
New Delhi, August 12, 2014
Net sales of the company increased 2.84 per cent to Rs 654.96 crore for the second quarter as compared to Rs 636.86 crore in the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.


www.businesstoday.in
New Delhi, July 24, 2014
The pricing anomaly has been caught by National Pharmaceutical Pricing Authority which has filed 22 cases this year alone, sending out demand notices that add up to Rs 221.78 crore.


www.businesstoday.in
July 15, 2014
\"By issuing a price control order under Para 19 without any consultation with the industry bodies, the NPPA has shocked and disappointed the pharma industry,\" said Shailesh Ayyangar, Managing Director India and Vice-President (South Asia), Sanofi India Limited, one of the companies likely to be affected by this move.  


www.businesstoday.in
July 14, 2014
India last year raised the number of drugs that are subject to price controls to cover up to 30 per cent of the total medication sold in the country, according to industry officials.


PAGES 3 OF 5  12345